Brachytherapy quality assurance in the PORTEC-4a trial for molecular-integrated risk profile guided adjuvant treatment of endometrial cancer

B.G. Wortman*, E. Astreinidou, M.S. Laman, E.M. van der Steen-Banasik, L.C.H.W. Lutgens, H. Westerveld, F. Koppe, A. Slot, H.A. van den Berg, M.E. Nowee, S. Bijmolt, T.C. Stam, A.G. Zwanenburg, J.W.M. Mens, I.M. Jurgenliemk-Schulz, A. Snyers, C.M. Gillham, N. Weidner, S. Kommoss, K. VandecasteeleV. Tomancova, C.L. Creutzberg, R.A. Nout, PORTEC Study Grp

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Web of Science)
Original languageEnglish
Pages (from-to)160-166
Number of pages7
JournalRadiotherapy and Oncology
Publication statusPublished - 1 Feb 2021


  • Endometrial cancer
  • Brachytherapy
  • Quality assurance
  • Dummy run

Cite this